Dr. Amol Soin, The Founder, and CEO of Soin Neuroscience
The new neuroscience development would treat bladder incontinence.
FREMONT, CA: Soin Neuroscience Inc., a biotech startup, has come up with a novel implantable sacral nerve stimulator to treat bladder incontinence. This new development predominantly caters to solve the problem and inconvenience of urinary incontinence that mostly occurs due to a condition known as overactive bladder, according to the American Urological Association. Sources say that in America, around 46 million people about 40 years of age or even older have continually reported symptoms of bladder incontinence. This startup company has developed an implantable device where small electrical leads are placed in an area of nerves in the sacral foramen.
The new sacral nerve stimulator is a neurological implant that works on a new and company’s proprietary algorithm that may cure the symptoms. This technique is known as "Sacral Neuromodulation" in medical device language. Soin Neuroscience Inc. is excited about the new product. This sacral nerve stimulation platform is said to a unique first in the industry. The product is expected to have an increased number of advantages over the current technology and has been a smarter addition to the market of neuromodulation devices.
Soin Neuroscience Inc. is a biotech company that is based in Dayton, OH. The company has started a medical device division lately, and it a lot of neuromodulation technologies in the developmental stage. Soin Neuroscience Inc. is also working on technologies such as machine learning, deep learning, and artificial intelligence in order to help enhance the process of making decisions for the doctors and physicians and enable the practical essence of precision medicine.